Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Explore the detailed record of transactions filed by Bellinger Andrew. Officer active across 1 company, notably Verve Therapeutics, Inc.. In total, 14 filings have been published. Breakdown: 1 buy · 6 sells. Total volume traded: €2.7m. Activity tracked since 21 June 2021. The latest transaction was disclosed on 14 December 2022 (Levée d'options). Regulator: SEC (Form 4). All data is free.
Companies and markets linked to Bellinger Andrew
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
5,000 shares@ US$19.002.7% of flowCommon StockSEC:0000899243-21-025071:0
Canonical exit: 19 Sept 2021 (T+90)
14 of 14 declarations
About Bellinger Andrew
Bellinger Andrew is a declarant linked to Verve Therapeutics, Inc., where the listed role is CSO & CMO. Across 14 total filings, the 14 sampled filings run from 2021-06-21 to 2022-12-16, with buy volume of EUR 79748 and sell volume of EUR 2573861, and the most frequent transaction nature is Option exercise.